Modulation of serotonergic receptor signaling and cross-talk by prion protein

被引:49
|
作者
Mouillet-Richard, S
Pietri, M
Schneider, B
Vidal, C
Mutel, V
Launay, JM
Kellermann, O
机构
[1] Inst Andre Lwoff, CNRS, UPR 1983, F-94801 Villejuif, France
[2] Inst Pasteur, Dept Biol Cellulaire & Infect, F-75724 Paris 15, France
[3] Commissariat Energie Atom, Serv Neurovirol, F-92265 Fontenay Aux Roses, France
[4] F Hoffmann La Roche Ltd, Pharma Res Dept, CH-4070 Basel, Switzerland
[5] Hop Lariboisiere, Serv Biochem, IFR6, F-75009 Paris, France
[6] Fac Pharm Paris 5, EA3621, Paris, France
关键词
D O I
10.1074/jbc.M406199200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The inducible serotonergic 1C11(5-HT) cell line expresses a defined set of serotonergic receptors of the 5-HT2B, 5-HT1B/D, and 5-HT2A subtypes, which sustain a regulation of serotonergic associated functions through G-protein-dependent signaling. 1C11(5-HT) cells have been instrumental to assign a signaling function to the cellular prion protein PrPC. Here, we establish that antibody-mediated ligation of PrPC concomitant to agonist stimulation of 5-HT receptors modulates the couplings of all three serotonergic receptors present on 1C11(5-HT) cells. Specific impacts of PrP antibodies were monitored depending on the receptor and pathway considered. PrPC ligation selectively cancels the 5-HT2A-PLC response, decreases the 5-HT1B/D negative coupling to adenylate cyclase, and potentiates the 5-HT2B-PLA2 coupling. As a result, PrPC ligation disturbs the functional interactions occurring between the signaling pathways of the three receptor subtypes. In 1C11(5-HT) cells, antagonizing cross-talks arising from 5-HT2B and 5-HT2A receptors control the 5-HT1B/D function. PrPC ligation reinforces the negative regulation exerted by 5-HT2B on 5-HT1B/D receptors. On the other hand it abrogates the blocking action of 5-HT2A on the regulatory loop linking 5-HT2B and 5-HT1B/D receptors. We propose that the ligation of PrPC affects the potency or dynamics of G-protein activation by agonist-bound serotonergic receptors. Finally, the PrPC-dependent modulation of 5-HT receptor couplings is restricted to 1C11(5-HT) cells expressing a complete serotonergic phenotype. It critically involves a PrPC-caveolin platform implemented on the neurites of 1C11(5-HT) cells during differentiation. Our findings define PrPC as a modulator of 5-HT receptor coupling to G-proteins and thereby as a protagonist contributing to the homeostasis of serotonergic neurons. They provide a foundation for uncovering the impact of prion infection on serotonergic functions.
引用
收藏
页码:4592 / 4601
页数:10
相关论文
共 50 条
  • [1] GnRH receptor signaling: Cross-talk of Ca2+ and protein kinase C
    Naor, Z
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 1997, 136 (02) : 123 - 127
  • [2] Cross-talk and modulation of signaling between somatostatin and growth factor receptors
    Ujendra Kumar
    Endocrine, 2011, 40 : 168 - 180
  • [3] Cross-talk and modulation of signaling between somatostatin and growth factor receptors
    Kumar, Ujendra
    ENDOCRINE, 2011, 40 (02) : 168 - 180
  • [4] Cross-Talk between PPARγ and Insulin Signaling and Modulation of Insulin Sensitivity
    Leonardini, Anna
    Laviola, Luigi
    Perrini, Sebastio
    Natalicchio, Annalisa
    Giorgino, Francesco
    PPAR RESEARCH, 2009, 2009
  • [5] BMP receptor signaling: Transcriptional targets, regulation of signals, and signaling cross-talk
    Miyazono, K
    Maeda, S
    Imamura, T
    CYTOKINE & GROWTH FACTOR REVIEWS, 2005, 16 (03) : 251 - 263
  • [6] Astrocyte microglia cross-talk in prion diseases and beyond
    Krasemann, S.
    GLIA, 2021, 69 : E92 - E93
  • [7] Signaling cross-talk in the resistance to HER family receptor targeted therapy
    H Yamaguchi
    S-S Chang
    J L Hsu
    M-C Hung
    Oncogene, 2014, 33 : 1073 - 1081
  • [8] Signaling cross-talk in the resistance to HER family receptor targeted therapy
    Yamaguchi, H.
    Chang, S-S
    Hsu, J. L.
    Hung, M-C
    ONCOGENE, 2014, 33 (09) : 1073 - 1081
  • [9] Cross-talk in cell death signaling
    Roy, S
    Nicholson, DW
    JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (08): : F21 - F25
  • [10] Cross-talk between bone morphogenic proteins and estrogen receptor signaling
    Yamamoto, T
    Saatcioglu, F
    Matsuda, T
    ENDOCRINOLOGY, 2002, 143 (07) : 2635 - 2642